1508 related articles for article (PubMed ID: 19294467)
41. Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan.
Isaji S; Kawarada Y; Taoka H; Tabata M; Suzuki H; Yokoi H
J Hepatobiliary Pancreat Surg; 1999; 6(2):108-16. PubMed ID: 10398896
[TBL] [Abstract][Full Text] [Related]
42. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
Yedibela S; Demir R; Zhang W; Meyer T; Hohenberger W; Schönleben F
Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
[TBL] [Abstract][Full Text] [Related]
43. An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma.
Tajima Y; Kuroki T; Fukuda K; Tsuneoka N; Furui J; Kanematsu T
Br J Surg; 2004 Jan; 91(1):99-104. PubMed ID: 14716802
[TBL] [Abstract][Full Text] [Related]
44. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
[TBL] [Abstract][Full Text] [Related]
45. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.
Hyder O; Marques H; Pulitano C; Marsh JW; Alexandrescu S; Bauer TW; Gamblin TC; Sotiropoulos GC; Paul A; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Popescu I; Gigot JF; Mentha G; Feng S; Pawlik TM
JAMA Surg; 2014 May; 149(5):432-8. PubMed ID: 24599477
[TBL] [Abstract][Full Text] [Related]
46. Indications for laparoscopic liver resection of mass-forming intrahepatic cholangiocarcinoma.
Kinoshita M; Kanazawa A; Takemura S; Tanaka S; Kodai S; Shinkawa H; Shimizu S; Murata A; Nishio K; Hamano G; Ito T; Tsukamoto T; Kubo S
Asian J Endosc Surg; 2020 Jan; 13(1):46-58. PubMed ID: 30924307
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment.
Li YY; Li H; Lv P; Liu G; Li XR; Tian BN; Chen DJ
J Gastrointest Surg; 2011 Apr; 15(4):608-13. PubMed ID: 21246412
[TBL] [Abstract][Full Text] [Related]
48. Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors?
Ercolani G; Dazzi A; Giovinazzo F; Ruzzenente A; Bassi C; Guglielmi A; Scarpa A; D'Errico A; Pinna AD
Eur J Surg Oncol; 2015 Sep; 41(9):1162-9. PubMed ID: 26095704
[TBL] [Abstract][Full Text] [Related]
49. Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections.
Saiura A; Yamamoto J; Kokudo N; Koga R; Seki M; Hiki N; Yamada K; Natori T; Yamaguchi T
Am J Surg; 2011 Feb; 201(2):203-8. PubMed ID: 19427630
[TBL] [Abstract][Full Text] [Related]
50. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma.
Miyazaki M; Ito H; Nakagawa K; Ambiru S; Shimizu H; Okaya T; Shinmura K; Nakajima N
J Am Coll Surg; 1999 Dec; 189(6):575-83. PubMed ID: 10589594
[TBL] [Abstract][Full Text] [Related]
51. Improved Postoperative Survival for Intraductal-Growth Subtype of Intrahepatic Cholangiocarcinoma.
Dover LL; Jacob R; Wang TN; Richardson JH; Redden DT; Li P; DuBay DA
Am Surg; 2016 Nov; 82(11):1133-1139. PubMed ID: 28206944
[TBL] [Abstract][Full Text] [Related]
52. Long-term results of surgical treatment of intrahepatic cholangiocarcinoma.
Gurmikov BN; Vishnevsky VA; Kovalenko YA; Chzhao AV
Khirurgiia (Mosk); 2020; (5):5-11. PubMed ID: 32500683
[TBL] [Abstract][Full Text] [Related]
53. Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma.
Isa T; Kusano T; Shimoji H; Takeshima Y; Muto Y; Furukawa M
Am J Surg; 2001 Jun; 181(6):507-11. PubMed ID: 11513774
[TBL] [Abstract][Full Text] [Related]
54. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
55. Factors predicting surgical resection in patients with intrahepatic cholangiocarcinoma and cirrhosis.
Li H; Wu JS; Wang XT; Lv P; Gong LS; Liu G; Tian BN; Li YY; Jiang B
J Invest Surg; 2014 Aug; 27(4):219-25. PubMed ID: 24476002
[TBL] [Abstract][Full Text] [Related]
56. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.
Lee SG; Song GW; Hwang S; Ha TY; Moon DB; Jung DH; Kim KH; Ahn CS; Kim MH; Lee SK; Sung KB; Ko GY
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):476-89. PubMed ID: 19851704
[TBL] [Abstract][Full Text] [Related]
57. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.
Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS
BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927
[TBL] [Abstract][Full Text] [Related]
58. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors.
Klempnauer J; Ridder GJ; von Wasielewski R; Werner M; Weimann A; Pichlmayr R
J Clin Oncol; 1997 Mar; 15(3):947-54. PubMed ID: 9060532
[TBL] [Abstract][Full Text] [Related]
59. Long-term outcome after surgical resection for cholangiocarcinoma and prognostic index value.
Wang Y; Duan B; Yan L; Shen C; Wu B; Luo J; Shen F; Zhao G
Surgeon; 2016 Feb; 14(1):38-43. PubMed ID: 25263386
[TBL] [Abstract][Full Text] [Related]
60. Pathological confirmation of para-aortic lymph node status as a potential criterion for the selection of intrahepatic cholangiocarcinoma patients for radical resection with regional lymph node dissection.
Nakayama T; Tsuchikawa T; Shichinohe T; Nakamura T; Ebihara Y; Hirano S
World J Surg; 2014 Jul; 38(7):1763-8. PubMed ID: 24378552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
